(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of 5.76% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.86%.
Inogen's revenue in 2025 is $347,028,000.On average, 4 Wall Street analysts forecast INGN's revenue for 2025 to be $9,847,025,906, with the lowest INGN revenue forecast at $9,450,386,584, and the highest INGN revenue forecast at $10,148,102,572. On average, 4 Wall Street analysts forecast INGN's revenue for 2026 to be $10,668,267,487, with the lowest INGN revenue forecast at $10,080,774,336, and the highest INGN revenue forecast at $11,162,912,829.
In 2027, INGN is forecast to generate $11,079,295,504 in revenue, with the lowest revenue forecast at $10,644,919,792 and the highest revenue forecast at $11,405,348,773.